Introduction {#S1}
============

Following a review of more than 240 articles on excessive game playing, the American Psychiatric Association's Substance Use and Related Disorders Workgroup ([@B35]) for the fifth edition of *Diagnostic and Statistical Manual of Mental Disorders (DSM-5)* concluded that Internet gaming disorder (IGD) is a condition for which future research might lend to a formal diagnosis ([@B2]). The DSM-5 proposed a set of nine potential criteria for the identification of this condition, but it noted that greater information is needed regarding these criteria and the assessment of this condition as well as its nature, comorbidities, and treatment response ([@B2]).

Since the publication of the DSM-5, more research on the assessment, epidemiology, and treatment of IGD has emerged. For example, Petry et al. ([@B35]) provided suggested interpretations of the DSM-5 criteria. Although not all agreed with them ([@B12]; [@B19]), Petry et al. ([@B36]) reported that many of these suggestions and interpretations were considered in the initial deliberations. Furthermore, the DSM-5 guidelines and criteria appear to be appropriate for classifying persons with clinically significant problems related to gaming ([@B25]; [@B36]; [@B40]).

Recently, the debate that IGD would be included as a mental disorder in the International Classification of Diseases (ICD)-11 has emerged. From the clinical and public health perspective, Rumpf et al. ([@B39]) and King et al. ([@B24]) suggested that IGD should be classified as a mental disorder. However, Aarseth et al. ([@B1]) identified fundamental problems in the inclusion of the IGD criteria in ICD-11. Based on substance use and gambling criteria, the premature inclusion of IGD criteria in ICD-11 may lead to false-positive cases in children and adolescents, which may have negative implications for a majority of healthy game users.

In addition to classification, understanding a disease's natural course is fundamental to evaluating its epidemiology ([@B5]) and treatment ([@B37]). In a review of longitudinal studies on IGD, Mihara and Higuchi ([@B30]) found that the course of IGD is variable and it may depend, in part, on age. For example, the prevalence rates of IGD in adolescents did not change substantially over time; however, they significantly decreased over periods ranging from 6 months to 5 years in adults ([@B30]). Similarly, a study of 3,034 Singaporean adolescents ([@B11]) found that 84% of those with IGD at baseline still reported having symptoms in a 2-year follow-up survey. Other studies have focused on evaluating rates of recovery and relapse following psychological or pharmacological treatments for IGD ([@B10]; [@B13]; [@B14]). These studies generally found that the prognosis for IGD is associated with the presence of underlying disorders, such as attention-deficit hyperactivity disorder (ADHD) and major depressive disorder (MDD), as well as with family cohesion. However, the limitations of these studies include small sample sizes, lack of consistent criteria for assessing IGD, and short follow-up periods.

This study is a naturalistic follow-up of over 750 patients who received professional treatment for IGD over a 5-year period from 2010 to 2015. First, we report the natural rates of treatment completion for the recommended 8-week course of treatment and examine baseline differences between those who completed the initial course of treatment and those who did not. Patients who were still struggling with gaming problems were encouraged to remain in treatment after the 8-week treatment ended. Therefore, we also evaluated predictors of continued treatment beyond the initial 8 weeks. Finally, we invited all patients who completed the initial 8-week treatment to attend an in-person follow-up evaluation in 2016--2017. We report the rates of continued gaming problems at this 1- to 5-year follow-up, as well as baseline predictors of recovery from gaming problems in these patients. We hypothesized that age may impact treatment completion and long-term recovery, and comorbid conditions may adversely influence response to treatment, and that better social interactions and supportive family environments during treatment initiation would be associated with better treatment outcomes.

Materials and Methods {#S2}
=====================

Study population {#S2a}
----------------

The sample was drawn from 755 patients who registered at Chung Ang University Hospital's Online Game Clinic and Research Center from June 2010 to December 2015. Of the 755 original patients, 477 successfully completed the initial 8 weeks of recommended care and the remaining 278 (36.8%) did not complete the 8-week treatment course. From December 1, 2016 to February 1, 2017, the hospital staff attempted to contact the initial cohort who successfully completed the initial 8 weeks of recommended care. However, 110 (23.1% of those who completed the initial 8 weeks of treatment) patients did not respond to either phone calls or text messages and were considered lost for follow-up assessment. The other 367 patients agreed to participate in the follow-up assessment. Table [1](#T1){ref-type="table"} shows the demographic and pretreatment characteristics of the full sample, and of the completer and non-completer groups.

###### 

Demographic characteristics

                                     Total (755)        Completers (*n* = 477)   Non-completers (*n* = 278)  
  ---------------------------- ----------------------- ------------------------ ---------------------------- -------------------------
  Age (years)\*                  22.4 ± 6.1 (11--44)     21.6 ± 5.9 (11--44)        22.8 ± 5.9 (12--42)      *t* = −2.73, *p* \< .01
  Age category                                                                                               
   \<20 (*N*)                        312 (41.3%)             212 (44.4%)                100 (36.0%)          χ^2^ = 6.09, *p* = .05
   20--30 (*N*)                      355 (47.0%)             216 (45.3%)                139 (50.0%)          
   30+ (*N*)                         88 (11.7%)               49 (10.3%)                 39 (14.0%)          
  Sex (male/female)              622/33 (95.6%/4.4%)     454/23 (95.2%/4.8%)        268/10 (96.4%/3.6%)      χ^2^ = 0.63, *p* = .48
  School years (years)           11.1 ± 2.4 (4--16)       10.7 ± 2.6 (4--16)         11.0 ± 2.2 (6--16)      *t* = −1.66, *p* = .08
  Game genre                                                                                                 
   MMORPG                            295 (39.1%)             192 (40.3%)                103 (37.1%)          χ^2^ = 0.99, *p* = .80
   RTS                               309 (40.9%)             193 (40.5%)                116 (41.7%)          
   FPS                               77 (10.2%)               48 (10.1%)                 29 (10.4%)          
   Others                             74 (9.8%)               44 (9.2%)                  30 (10.8%)          
  Year of initial treatment                                                                                  
   2015                              191 (25.3%)             115 (24.1%)                 76 (27.3%)          χ^2^ = 7.19, *p* = .21
   2014                              165 (21.9%)              97 (20.3%)                 68 (24.5%)          
   2013                              128 (17.0%)              78 (16.4%)                 50 (18.0%)          
   2012                              97 (12.8%)               65 (13.6%)                 32(11.5%)           
   2011                              109 (14.4%)              74 (15.5%)                 35 (12.6%)          
   2010                               65 (8.6%)               48 (10.1%)                 17 (6.1%)           
  Diagnosis                                                                                                  
   Only IGD                          273 (36.2%)             161 (33.8%)                112 (40.3%)          χ^2^ = 5.43, *p* = .25
   IGD + ADHD                        203 (26.9%)             137 (28.7%)                 66 (23.7%)          
   IGD + MDD                         198 (26.2%)             127 (26.6%)                 71 (25.5%)          
   IGD + ADHD + MDD                   44 (5.8%)               31 (6.5%)                  13 (4.7%)           
   IGD + others                       37 (4.9%)               21 (4.4%)                  16 (5.8%)           
  Clinical scale scores                                                                                      
   IQ                           98.4 ± 14.6 (50--143)   98.2 ± 14.3 (50--143)           98.7 ± 15.1          *t* = 0.13, *p* = .89
   YIAS                          63.7 ± 9.6 (50--93)     64.1 ± 9.7 (51--93)        63.2 ± 8.98 (51--91)     *t* = 1.38, *p* = .17
   K-ADHD-RS                     20.9 ± 12.4 (0--68)     21.0 ± 13.0 (0--63)        20.2 ± 13.0 (0--66)      *t* = 1.26, *p* = .23
   BDI                           15.0 ± 9.0 (0--46)       15.1 ± 9.2 (0--46)             14.8 ± 9.2          *t* = 0.40, *p* = .69
   BAI                            9.1 ± 7.8 (0--47)       9.5 ± 7.8 (0--47)              8.7 ± 7.8           *t* = 0.52, *p* = .25
   BIS/BAS                       53.5 ± 9.0 (5--98)      53.7 ± 9.1 (27--98)             53.1 ± 8.4          *t* = 0.96, *p* = .34
  Social interaction factors                                                                                 
   FES\*                         10.2 ± 3.1 (4--25)       10.4 ± 3.2 (4-25)              9.6 ± 2.7           *t* = 3.69, *p* \< .01
   SADS\*                       79.7 ± 14.2 (39--130)   77.8 ± 13.4 (39--130)           80.6 ± 13.7          *t* = −2.78, *p* \< .01
  Smoking                                                                                                    
   Heavy smoker                       70 (9.3%)               43 (9.0%)                  27 (9.7%)           χ^2^ = 1.54, p = 0.46
   Occasional smoker                 230 (30.5%)             153 (32.1%)                 77 (27.7%)          
   No use                            455 (60.3%)             281 (58.9%)                174 (62.6%)          
  Alcohol use                                                                                                
   Heavy alcohol use                  26 (2.3%)               19 (4.0%)                   7 (2.5%)           χ^2^ = 4.25, *p* = .12
   Occasional alcohol use            300 (39.1%)             200 (41.9%)                100 (36.0%)          
   No use                            429 (58.6%)             258 (54.1%)                171 (62.6%)          

*Note.* IGD: Internet gaming disorder; K-ADHD-RS: Korean-Attention Deficit Hyperactivity Disorder-Rating Scale; BDI: Beck Depressive Inventory; BAI: Beck Anxiety Inventory; BIS/BAS: Behavioral Inhibitory System/Behavioral Activation System Scale; FES: Family Environmental Scale; SADS: Social Avoidance and Distress Scale; MMORPG: massively multiplayer online role-playing game; RTS: real-time strategy; FPS: first-person shooter; IGD + others: IGD + autism spectrum disorder, bipolar disorder, or mental retardation; MDD: major depressive disorder; IQ: intelligent quotient.

\*Statistically significant.

Inclusion of patients and diagnosis of IGD {#S2b}
------------------------------------------

The criteria for treatment and inclusion in this study were: (a) Internet game playing of more than 4 hr per day or 30 hr per week, (b) scoring \>50 points on the Young Internet Addiction Scale (YIAS), and one or more of the following indicators of significant gaming-related distress: (a) irritable, anxious, and aggressive behaviors upon others' request to stop Internet game play; (b) economic problems or substantial family and/or social problems; (c) disruptive diurnal rhythms (difficulty waking up due to reduced sleep at night related to Internet game play); or (d) loss of job or school truancy.

Study procedure {#S2c}
---------------

Psychiatrists assessed patients for ADHD, MDD, mental retardation, and developmental disorders using the Structured Clinical Interview of DSM-IV-TR. All patients were asked to complete questionnaires regarding the severity of their IGD, demographic features, psychological symptoms, and social interactions. The YIAS was used to determine IGD symptom severity. Demographic information included age, sex, years of follow-up, game genre, and alcohol and tobacco use. For game genre, patients were asked to select their preference among four categories: massively multiplayer online role-playing games, real-time strategy, first-person shooter, or other. Tobacco and alcohol use were categorized as no use, occasional use (less than five cigarettes a day or drinking less than 5 days per month on an average), or regular/heavy use (more than five cigarettes per day or binge drinking on 5 or more days per month) ([@B20]; [@B33]).

Psychological factors measured at treatment initiation included intelligence quotient (IQ), ADHD, MDD, anxiety, and impulsivity. IQ was estimated using the Korean-Wechsler Adult Intelligence Scale (K-WAIS), which has an internal consistency ranging from .78 to .94 ([@B21]). Severity of ADHD symptoms was assessed using the Korean version of Dupaul's ([@B8]) ADHD Rating Scale (K-ADHD-RS) with adequate reliability (an internal consistency ranging from .77 to .89 and test--retest reliability = .85) and adequate to excellent validity (excellent construct validity, adequate discriminative validity, and adequate treatment sensitivity) ([@B9]). This version of the ADHD-RS has been validated by So, Noh, Kim, Ko, and Koh ([@B41]). Depression and anxiety symptoms were assessed using the Beck Depression Inventory (BDI), which has an internal consistency ranging from .75 to .85 ([@B4]) and the Beck Anxiety Inventory (BAI) with an internal consistency of .93. The Korean versions of the BDI and BAI were validated by Rhee et al. ([@B100]) and Kwon ([@B26]), respectively. Impulsivity was assessed using the Behavioral Inhibitory System/Behavioral Activation System (BIS/BAS) Scale ([@B7]), with an internal consistency ranging from .78 to .79. The Korean version of the BIS/BAS Scale has been validated by Kim and Kim ([@B22]). Using a sample of 1,515 people, Poythress et al. ([@B38]) reported adequate reliability and validity of the BIS/BAS Scale.

The social interaction factors that are examined included family cohesion and social intimacy. Family cohesion was assessed using the Family Environment Scale (FES; [@B31]), which has adequate reliability (a test--retest reliability ranging from .68 to .86) and adequate to excellent validity (adequate construct validity and excellent discriminative validity). Its Korean version has been validated by So et al. ([@B41]). Higher FES scores reflect better family environments. Social intimacy was assessed using the Social Avoidance and Distress Scale (SADS; [@B42]), which has adequate reliability (test--retest reliability of .68) and validity (construct and discriminative validity), with lower scores indicative of better functioning. The Korean version of the SADS has been validated by Lee and Choi ([@B28]).

After completing these measures during initial treatment presentation, all patients were offered treatment involving cognitive--behavioral therapy and medications for symptoms of depressive mood, poor attention, and impulse and behavior control ([@B23]). At the end of the 8-week course of treatment, patients who had not fully recovered from IGD were offered additional care following discussions among patients, caretakers, and psychiatrists. These additional treatments included medications for underlying diseases and supportive psychotherapy that were provided until recovery from IGD or until the patient terminated care. At the follow-up evaluation conducted in 2016--2017, occurring from 1 to 5 years after the initial presentation for treatment, a diagnosis of IGD was based on the DSM-5 diagnostic criteria ([@B2]). The agreement between two psychiatrists' diagnoses of IGD at follow-up was κ = 0.89.

Model and statistical analysis {#S2d}
------------------------------

Descriptive statistics included means and standard deviations for continuous variables, as well as counts and percentages for categorical variables. Independent *t*-tests were used to compare demographic information, including age and school years; IQ; and scores on the YIAS, K-ADHD-RS, BDI, BAI, BIS/BAS, FES, and SADS for completers and non-completers. χ^2^ tests were used to compare the groups on sex, game genre, smoking and alcohol use, comorbid psychiatric diagnoses, and year of initial treatment. An α \< .05 level was considered statistically significant.

Next, a logistic regression analysis was conducted to identify the predictors of the completion of the 8-week treatment in the entire sample. Independent variables included age; school year; gender; game genre; year of treatment; YIAS, BDI, BAI, BIS/BAS, SADS, FES, K-ADHD-RS, and IQ scores; and smoking and alcohol use. The dependent variable, completion of the 8-week treatment, was operationalized as a binary code (1: completion/0: non-completion). In addition, we used a logistic regression analysis to identify the predictors of receiving more than 8 weeks of treatment among the 477 completers. The independent variables were identical to those outlined above. Finally, we used a third multivariate logistic regression analysis to identify the predictors of recovery from IGD among the 367 completers who participated in the follow-up evaluation. In this analysis, the independent variables included the same variables as those in the initial regression, in addition to whether the patient received more than the initial 8 weeks of treatment. The dependent variable, recovery from IGD, was operationalized based on clinical impressions using the DSM-5's diagnostic criteria for IGD ([@B2]). All analyses were performed using Statistical Analysis System, version 9 (SAS^®^, SAS Institute Inc., NC, USA).

Ethics {#S2e}
------

The study procedures were performed in accordance with the Declaration of Helsinki. The institutional review board of Chung-Ang University Hospital approved the research protocol for this study. All participants were informed about the procedures of this study and provided written informed consent. The written informed consent was provided by patients aged 18 years or above. For patients aged below 18 years, informed assent was obtained from their parents who provided written informed consent.

Results {#S3}
=======

Comparison of demographic characteristics between 8-week treatment completers and non-completers {#S3a}
------------------------------------------------------------------------------------------------

In the entire sample, 63.1% of the patients completed 8 weeks of treatment. Univariate analyses revealed that completers were significantly younger and had better FES and social avoidance scores as compared to the non-completers (Table [1](#T1){ref-type="table"}).

The logistic regression analyses also evaluated the unique predictive impact of these variables (data not shown, but they are available from the authors). The overall model was significant in predicting failure to complete 8 weeks of treatment, χ^2^(19) = 54.84, *p* \< .001. Similar to the results derived from the univariate analyses, significant predictors of the completion of 8 weeks of treatment were age, β = −0.05 (*SE* = 0.01), Wald = −3.25, *p* \< .01, odds ratio = 0.95 \[95% confidence interval (CI) = 0.93--0.98\]; lower social avoidance, β = −0.02 (*SE* = 0.01), Wald = −2.66, *p* = .01, odds ratio = 0.99 (95% CI = 0.97--1.00); and better family environment, β = −0.11 (*SE* = 0.03), Wald = 3.61, *p* \< .01, odds ratio = 0.90 (95% CI = 1.05--1.18). No other variables significantly predicted completion of treatment.

Logistic regression predicting extended treatment (n = 477) {#S3b}
-----------------------------------------------------------

Independent predictors of extended treatment were higher baseline scores on the YIAS, BDI, and K-ADHD-RS (Table [2](#T2){ref-type="table"}). Among the completers (*n* = 477), 298 (62.5%) were offered and received additional treatment, with an average of 5.1 ± 3.6 additional months of treatment (ranging from 1 to 27 months).

###### 

Logistic regression predicting extended treatment (*n* = 477)

                                                       β           *SE*   Wald    *p*     OR     95% CI   
  ---------------------------------------------------- ----------- ------ ------- ------- ------ -------- ------
  Age                                                  −0.03       0.02   −1.57   .12     0.97   0.93     1.01
  Years of schooling                                   0.15        0.09   3.17    .09     1.16   0.99     1.39
  Gender[a](#T2-fn1){ref-type="table-fn"}                                                                 
   Female                                              Reference                                          
   Male                                                0.16        0.43   0.37    .71     1.17   0.51     2.70
  Game genre[a](#T2-fn1){ref-type="table-fn"}                                                             
   MMORPG                                              Reference                                          
   RTS                                                 0.29        0.23   1.27    .21     1.34   0.85     2.10
   FPS                                                 0.55        0.38   1.45    .15     1.73   0.82     3.65
   Others                                              −0.19       0.37   −0.52   .61     0.82   0.39     1.72
  Year of treatment[a](#T2-fn1){ref-type="table-fn"}   −0.06       0.06   −0.88   .38     0.95   0.83     1.07
  Clinical scale                                                                                          
   IQ                                                  −0.01       0.01   −1.23   .22     0.99   0.97     1.01
   YIAS[\*](#T2-fn2){ref-type="table-fn"}              0.04        0.01   2.92    .01     1.04   1.01     1.08
   BDI[\*](#T2-fn2){ref-type="table-fn"}               0.03        0.01   2.19    .03     1.03   1.00     1.06
   BAI                                                 0.01        0.01   0.67    .51     1.01   0.98     1.04
   BIS/BAS                                             0.01        0.01   0.67    .51     1.02   0.95     1.09
   K-ADHD-RS[\*](#T2-fn2){ref-type="table-fn"}         0.03        0.01   3.05    \<.01   1.03   1.01     1.05
  Social interaction factors                                                                              
   SADS                                                0.01        0.01   1.09    .28     1.01   0.99     1.03
   FES                                                 0.02        0.04   0.46    .65     1.03   0.95     1.09
  Smoking status[a](#T2-fn1){ref-type="table-fn"}                                                         
   Heavy smoker                                        Reference                                          
   Occasional smoker                                   −0.23       0.37   −0.61   .54     0.80   0.38     1.66
   No use                                              −0.07       0.45   −0.15   .88     0.94   0.39     2.25
  Alcohol use[a](#T2-fn1){ref-type="table-fn"}                                                            
   Heavy alcohol use                                   Reference                                          
   Occasional alcohol use                              −0.59       0.52   −1.14   .26     0.55   0.20     1.53
   No use                                              −0.89       0.59   −1.51   .13     0.41   0.13     1.31

*Note.* MMORPG: massively multiplayer online role-playing game; RTS: real-time strategy; FPS: first-person shooter; K-ADHD-RS: Korean-Attention Deficit Hyperactivity Disorder-Rating Scale; BDI: Beck Depressive Inventory; BAI: Beck Anxiety Inventory; BIS/BAS: Behavioral Inhibitory System/Behavioral Activation System Scale; FES: Family Environment Scale; SADS: Social Avoidance and Distress Scale; YIAS: Young Internet Addiction Scale; CI: confidence interval; OR: odds ratio; IQ: intelligent quotient; *SE*: standard error.

Categorical variables.

Statistically significant results at α = .05; dependent variable (1/0): more than 8 weeks of treatment/just 8 weeks of treatment.

Logistic regression predicting recovery from IGD at follow-up (n = 367) {#S3c}
-----------------------------------------------------------------------

Table [3](#T3){ref-type="table"} shows the results of the logistical regression analysis predicting continued treatment beyond the initial 8 weeks. The overall model was significant, χ^2^(19) = 57.59, *p* \< .001. The independent predictors of extended treatment were higher baselines scores on the YIAS, BDI, and K-ADHD-RS (Table [2](#T2){ref-type="table"}). Among those who completed at least the initial 8 weeks of treatment and who participated in the follow-up evaluation in 2016--2017, 253 (68.9%) patients were classified as having recovered from IGD. The key predictors of long-term recovery from IGD were older age, earlier admission to the clinic (longer length of follow-up), lower baseline BDI and K-ADHD-RS scores, and having received just 8 weeks of treatment.

###### 

Logistic regression predicting recovery from IGD at the follow-up (*n* = 367)

                                                        β           *SE*   Wald    *p*     OR     95% CI   
  ----------------------------------------------------- ----------- ------ ------- ------- ------ -------- -------
  Age[\*](#T3-fn2){ref-type="table-fn"}                 0.11        0.02   4.95    \<.01   1.12   1.07     1.17
  Years of schooling (year)                             0.09        0.07   1.92    .17     0.96   0.91     1.25
  Gender[a](#T3-fn1){ref-type="table-fn"}                                                                  
   Female                                               Reference                                          
   Male                                                 0.26        0.65   0.39    .69     1.29   0.36     4.66
  Game genre[a](#T3-fn1){ref-type="table-fn"}                                                              
   MMORPG                                               Reference                                          
   RTS                                                  −0.22       0.26   −0.85   .40     0.80   0.48     1.33
   FPS                                                  −0.07       0.41   −0.17   .86     0.93   0.41     2.09
   Others                                               0.08        0.46   0.17    .87     1.08   0.44     2.65
  Year of treatment[\*](#T3-fn2){ref-type="table-fn"}   −0.34       0.08   −3.96   \<.01   0.71   0.60     0.84
  Clinical scales                                                                                          
   IQ                                                   0.00        0.01   −0.27   .79     1.00   0.98     1.01
   YIAS                                                 −0.01       0.02   0.11    .14     0.96   0.91     1.01
   BDI[\*](#T3-fn2){ref-type="table-fn"}                −0.05       0.02   −3.02   \<.01   0.95   0.92     0.98
   BAI                                                  −0.02       0.02   −1.56   .12     0.98   0.95     1.01
   BIS/BAS                                              −0.02       0.01   −1.47   .14     0.98   0.95     1.01
   K-ADHD-RS[\*](#T3-fn2){ref-type="table-fn"}          −0.03       0.01   −3.53   \<.01   0.97   0.95     0.98
  Social interaction factors                                                                               
   SADS                                                 −0.01       0.01   −0.97   .33     0.99   0.98     1.01
   FES                                                  −0.05       0.04   −1.23   .22     0.95   0.89     1.03
  Smoking status[a](#T3-fn1){ref-type="table-fn"}                                                          
   Heavy smoker                                         Reference                                          
   Occasional smoker                                    0.13        0.50   0.26    .79     1.14   0.43     3.06
   No use                                               −0.28       0.64   −0.43   .67     0.76   0.22     2.66
  Alcohol use[a](#T3-fn1){ref-type="table-fn"}                                                             
   Heavy alcohol use                                    Reference                                          
   Occasional alcohol use                               0.01        0.76   0.02    .99     1.01   0.23     4.46
   No use                                               0.68        0.84   0.81    .42     1.97   0.38     10.22
  Extended treatment[a](#T3-fn1){ref-type="table-fn"}                                                      
   Beyond 8 weeks                                       Reference                                          
   Just 8 weeks[\*](#T3-fn2){ref-type="table-fn"}       1.57        0.35   17.66   \<.01   4.29   2.49     9.42

*Note.* MMORPG: massively multiplayer online role-playing game; RTS: real-time strategy; FPS: first-person shooter; K-ADHD-RS: Korean-Attention Deficit Hyperactivity Disorder-Rating Scale; BDI: Beck Depressive Inventory; BAI: Beck Anxiety Inventory; BIS/BAS: Behavioral Inhibitory System/Behavioral Activation System Scale; FES: Family Environment Scale; SADS: Social Avoidance and Distress Scale; YIAS: Young Internet Addiction Scale; CI: confidence interval; OR: odds ratio; IQ: intelligent quotient; *SE*: standard error.

Categorical variables.

Statistically significant results at α = .05; dependent variable (1/0): recovery from IGD/non-recovery from IGD.

Discussion {#S4}
==========

IGD patients who completed the 8-week treatment (completers) were younger, and had better family environments and lower social avoidance than their counterparts did. Most likely, younger age was associated with greater initial treatment completion, because families were more involved in encouraging treatment attendance. The importance of family environment has been emphasized in other studies on IGD ([@B14]; [@B27]; [@B43]), and poor cohesion and functioning between a parent and child are risk factors for gaming and Internet problems in general ([@B17]; [@B43]). Numerous studies have demonstrated associations between social anxiety symptoms and IGD ([@B18]; [@B40]), and data from this study suggest that those with greater social avoidance are less likely to complete the treatment course for IGD.

Not surprisingly, more severe gaming problems, as assessed by the YIAS during treatment initiation, were associated with greater likelihood of being offered extended treatment for IGD. In addition, greater depression and ADHD symptoms at baseline predicted the need for more extended care. Both depression and ADHD may lead to and/or stem from gaming problems ([@B3]; [@B15], [@B13]; [@B16]), and greater symptom severity during initiating treatment appears to be related to the need for more extensive care.

The key predictors of recovery from IGD at the long-term follow-up were having received only 8 weeks of treatment, earlier admission to the clinic (i.e., more years of follow-up), older age, and lower baseline BDI and ADHD scores. As noted earlier, those who were not offered extended treatment had lower baseline scores for gaming problem severity. Surprisingly, those who were considered as "recovered" at the end of the 8-week-treatment program could not be a predictor of extended recovery from IGD. Earlier admission was associated with better long-term outcomes, which may reflect better treatment provided in the earlier, relative to later, years, and/or that the patients "outgrew" their gaming problems as they aged. Older age at treatment initiation, which was related to poorer initial treatment completion, was associated with better long-term recovery. This may also be influenced by the age-related differences in follow-up completion in this sample, in which non-completers were more likely to be older at treatment initiation. Older completers may have been more likely to do well in treatment than their non-completer counterparts were. It is also possible that older non-completers may have dropped out of care, because they successfully stopped gaming. Future studies should evaluate long-term outcomes regardless of treatment completion.

Baseline depression and ADHD symptoms, which were associated with the need for more extended treatment, were also inversely related to long-term recovery. These psychological symptoms are associated with the development of IGD ([@B6]). Thus, this study extends the existing knowledge and acknowledges the need for more extended treatment as well as better long-term outcomes. We have previously demonstrated that treatment for IGD reduces ADHD ([@B15]) and depression ([@B13]) symptoms, but greater symptom severity during initiation also results in greater need for extended treatment and poorer rates of recovery from IGD. In this study, neither impulsivity nor general anxiety symptoms predicted treatment completion or outcomes.

Similarly, in this study, neither IQ, preferred form of game, nor substance use was associated with outcomes. All of these variables have been related to the development of gaming problems ([@B29]; [@B32]; [@B34]), but this is the first known study to examine their impact on outcomes of treatment for gaming problems. At least in this sample, they did not appear to impact the length of recommended treatment for IGD or long-term treatment outcomes.

There were several limitations to this study. First, we only attempted to follow-up patients who completed the initial 8 weeks of treatment, and about 25% of the initial treatment completers did not participate in the follow-up. Thus, our results may be influenced by factors that impacted dropout from treatment, as well as failure or refusal to complete the follow-up. The IGD criteria, as defined in the DSM-5, were not available when the initial cohort began treatment in 2010, but it is likely all participants initially had clinically significant problems with gaming. Typically, only persons with relatively severe symptoms seek treatment. This study was a naturalistic follow-up of patients who began treatment over a 5-year period. Therefore, naturally occurring changes in treatment, gaming, and the society may also have impacted the results. The duration of the follow-up period also differed substantially across cohorts, ranging from 1 to 5 years after treatment initiation. Moreover, this study did not evaluate the efficacy or even the consistency of the treatment applied. Therefore, the specificity of these outcomes may or may not relate to the interventions delivered. In future analyses, we will include scheduled follow-ups of clinical and psychological data.

Conclusions {#S5}
===========

Nearly two thirds of patients who initiated treatment for IGD completed an 8-week course of psychotherapy. Of these, about two thirds were not considered fully recovered and were offered additional care. Between 1 and 5 years later, about one third of the initial sample (253 of 755, 33.5%), or one half of the completers (253 of 477, 49.3%) were considered to have recovered from IGD. These data suggest that treatment for IGD is effective, but randomized controlled trials examining the effects of specific interventions are lacking. In designing and evaluating interventions, age, and family and social factors should be considered, since younger patients and those with greater family and social support exhibited improved initial engagement and response to treatment. On the other hand, older age and fewer depression and ADHD symptoms may be positively associated with long-term recovery from IGD.
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